Implant did not undergo required gamma radiation dose audit. A potential reduction in sterility assurance could lead to patient infection.
Source facts
Action
On 6/23/2026 customers were phoned and informed to return affected implants.
On 7/7/2026, recall notices were mailed to risk managers who were asked to do the following:
1) Cease use, distribution, and quarantine affected product.
2) Contact firm customer service to obtain instructions for returning product.
3) Email mail tracking numbers to firm.
4) Complete and return the acknowledgement and receipt form.
Questions can be directed to the firm at 470-419-1429
Initiated
2026-06-23
Root cause
Process change control
Distribution
US Nationwide distribution in the states of VT, FL, TN, NY, GA, TX, HI.
Recall number
Z-2958-2026
Recall status
Open, Classified
CDRH record ID
221452
FDA classified
2026-08-14
Recall event number
99383
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.